Physician profile
James Devanney
NPI 1821096579
$2,538.00
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $47.99 · 2021: $605 · 2022: $793 · 2023: $717 · 2024: $375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,014 · Education: $77.97.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,014.19 |
| Education | $77.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $315.90 | 2021-2024 | |
| Urovant Sciences INC | $280.44 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $279.99 | 2023-2024 | Gemtesa, Orgovyx |
| Acerus Pharmaceuticals Corporation | $255.05 | 2021-2022 | |
| Pfizer INC. | $229.09 | 2021-2023 | |
| Antares Pharma, INC. | $182.70 | 2022-2024 | Xyosted, Nocdurna, Tlando |
| Teleflex LLC | $151.87 | 2021-2024 | Urolift |
| Merck Sharp & Dohme LLC | $131.77 | 2021-2023 | Bridion, Lynparza, Keytruda |
| Boston Scientific Corporation | $131.65 | 2020-2024 | Solyx Sis System |
| Dentsply Ih INC. | $128.38 | 2020-2022 | |
| Axonics, INC. | $89.16 | 2021-2024 | Axonics |
| Halozyme INC | $58.99 | 2023 | |
| Dentsply Ih Ab | $52.81 | 2023 | Lofric |
| Hollister Incorporated | $35.32 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $31.04 | 2023 | Seglentis |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $29.75 | 2024 | |
| 180 Medical, INC. | $29.62 | 2023 | Gentlecath Glide |
| Medtronic, INC. | $28.04 | 2023 | Intellis Adaptivestim |
| Becton, Dickinson and Company | $26.91 | 2024 | Bard Urinary Drainage Bag |
| Myovant Sciences INC. | $24.04 | 2022 | |
| Telix Pharmaceuticals | $20.02 | 2023 | Illuccix |
| Photocure INC | $13.73 | 2023 | Cysview |
| Sagent Pharmaceuticals | $11.73 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Devanney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.